Agios Pharmaceuticals, Inc. (AGIO) market cap
Agios Pharmaceuticals, Inc. (AGIO) has a market cap of $1.79B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.58B. That is 17.0% lower than the $1.90B of fiscal 2024. Today's figure is 13.3% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 08:21 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Market cap today
- $1.79B
- Market cap, fiscal 2025
- $1.58B
- Change on fiscal 2024
- −17.0%
- Growth, 5 years
- −12.0% a year
- Highest on record
- $2.99Bfiscal 2020
- Lowest on record
- $1.24Bfiscal 2023
- Fiscal years on record
- 72019–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Agios Pharmaceuticals, Inc. market cap, in more detail
Over the five fiscal years to 2025 the market cap shrank at a compound 12.0% a year. Across the 7 fiscal year-ends on record (2019–2025), the highest was $2.99B in fiscal 2020 and the lowest $1.24B in fiscal 2023.
Market cap at each fiscal year-end
The last point is today's figure; the others are fiscal year-ends.
Agios Pharmaceuticals, Inc. market cap, year by year
| Fiscal year | Market cap | Change | Year ended | Share price at year-end | Diluted shares |
|---|---|---|---|---|---|
| Today | $1.79B | — | $29.89 | — | |
| 2025 | $1.58B | 17.0% down | $27.22 | 57.97M | |
| 2024 | $1.90B | 53.5% up | $32.86 | 57.89M | |
| 2023 | $1.24B | 19.4% down | $22.27 | 55.65M | |
| 2022 | $1.54B | 22.6% down | $28.08 | 54.79M | |
| 2021 | $1.99B | 33.5% down | $32.87 | 60.45M | |
| 2020 | $2.99B | 4.4% up | $43.33 | 69.00M | |
| 2019 | $2.86B | — | $47.75 | 59.99M | |
| 2018 | — | — | $46.11 | — | |
| 2017 | — | — | $57.17 | — | |
| 2016 | — | — | $41.73 | — | |
| 2015 | — | — | $64.92 | — | |
| 2014 | — | — | $112.04 | — | |
| 2013 | — | — | $23.95 | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.
How to read it
It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.
Agios Pharmaceuticals, Inc., figure by figure
- Agios Pharmaceuticals, Inc. revenue
- Agios Pharmaceuticals, Inc. earnings
- Agios Pharmaceuticals, Inc. earnings per share (EPS)
- Agios Pharmaceuticals, Inc. P/E ratio
- Agios Pharmaceuticals, Inc. P/S ratio
- Agios Pharmaceuticals, Inc. P/B ratio
- Agios Pharmaceuticals, Inc. free cash flow
- Agios Pharmaceuticals, Inc. operating margin
- Agios Pharmaceuticals, Inc. dividend
- Agios Pharmaceuticals, Inc. shares outstanding
- Agios Pharmaceuticals, Inc. total debt
- Agios Pharmaceuticals, Inc. cash on hand
- Agios Pharmaceuticals, Inc. total assets
- Agios Pharmaceuticals, Inc. return on equity (ROE)
- Agios Pharmaceuticals, Inc. return on invested capital (ROIC)
Agios Pharmaceuticals, Inc. (AGIO) overview: price, valuation and scorecard
Agios Pharmaceuticals, Inc. market cap: questions and answers
What is Agios Pharmaceuticals, Inc.'s market cap?
Agios Pharmaceuticals, Inc. (AGIO) has a market cap of $1.79B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.58B. That is 17.0% lower than the $1.90B of fiscal 2024.
What is the growth rate of Agios Pharmaceuticals, Inc.'s market cap?
Over the five fiscal years to 2025 the market cap shrank at a compound 12.0% a year.
What are the highest and lowest market cap figures on record for Agios Pharmaceuticals, Inc.?
Across the 7 fiscal year-ends on record (2019–2025), the highest was $2.99B in fiscal 2020 and the lowest $1.24B in fiscal 2023.
How is Agios Pharmaceuticals, Inc.'s market cap calculated?
Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: market cap
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Agios Pharmaceuticals, Inc. (AGIO) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/AGIO/market-cap
Underlying data: the company's filings with the SEC and Yahoo Finance.